You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 12, 2024

STRIDES PHARMA Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has two hundred and sixty approved drugs.

There are three tentative approvals on STRIDES PHARMA drugs.

Summary for STRIDES PHARMA
US Patents:0
Tradenames:157
Ingredients:153
NDAs:260
Patent Litigation for STRIDES PHARMA: See patent lawsuits for STRIDES PHARMA

Drugs and US Patents for STRIDES PHARMA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma TESTOSTERONE testosterone GEL;TRANSDERMAL 076744-002 May 23, 2007 AB1 RX No No ⤷  Sign Up ⤷  Sign Up
Strides Pharma GABAPENTIN gabapentin CAPSULE;ORAL 211314-003 Oct 16, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up
Strides Pharma MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 091588-002 Aug 3, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up
Strides Pharma OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 078109-003 Oct 24, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for STRIDES PHARMA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 5,583,152 ⤷  Sign Up
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-004 Jun 13, 1995 4,215,104 ⤷  Sign Up
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,105,776 ⤷  Sign Up
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,258,027 ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 10 mg and 20 mg ➤ Subscribe 2008-02-29
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.